HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1705 Cr | ₹8352 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 5.36% | 3.64% |
6 Month | 0.01% | -0.86% |
1 Year | 27.12% | 15.02% |
3 Year | - | 25.77% |
5 Year | - | 22.41% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 8.75% | 8.27% |
1 Year | 15.9% | 9.8% |
3 Year | - | 24.53% |
5 Year | - | 19.95% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 34.78% | 17.67% |
3 Year | - | 20.32% |
5 Year | - | 20.52% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 14.96% |
Sharp | - | 1.07% |
Beta | - | 0.90% |
Alpha | - | 1.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 5.67 | 1.42 |
Large Cap | 33.98 | 36.54 |
Mid Cap | 26.59 | 31.26 |
Small Cap | 33.75 | 30.78 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.02 | 1.42 |
Basic Materials | 2.2 | - |
Healthcare | 95.78 | 98.58 |
Top Comparisons
Mahindra Manulife Low Duration Fund - Regular Plan - Growth
3Y Returns6.84%
Aditya Birla Sun Life Low Duration Fund - Growth Plan
3Y Returns6.94%
DSP Flexi Cap Fund - Regular Plan - Growth
3Y Returns22.66%
Canara Robeco Flexicap Fund - Regular Plan - Growth Option
3Y Returns19.75%
Sundaram Services Fund Regular Plan - Growth
3Y Returns23.86%
HSBC Business Cycles Fund - Regular Growth
3Y Returns28.82%
WhiteOak Capital Liquid Fund- Regular plan-Growth Option
3Y Returns6.8%
HSBC Liquid Fund - Regular Growth
3Y Returns6.96%